Global Perspectives: Current and Future State of CAR T

Impact of COVID-19 in Europe and the US. Review of new and relevant clinical advances of CAR T in DLBCL, ALL, FL, and MCL, including recently presented abstracts at ASCO and EHA.

June 22 & 24, 2020


Marie José Kersten, MD, PhD

Academic Medical Center – University of Amsterdam, The Netherlands

Frederick Locke MD


Frederick Locke, MD

Moffitt Cancer Center Tampa, FL, US

Faculty Members

Catherine Thieblemont, MD, PhD
Hôpital Saint-Louis, Paris, France

Martin Dreyling, MD
University of Munich Hospital, Großhadern, Germany

Paolo Corradini, MD
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Sattva Neelapu, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, US

Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, US

Max Topp, MD
University Hospital, Würzburg, Germany

Sample Report

Start discovering the insights

View Report


Clinical experts from across the globe discuss the impact of COVID-19 in Europe and the US and recommendations regarding the management of patients on CAR T therapy. The virtual meeting and summary report will include detailed reviews, discussion, and commentary on recent clinical advances in the use of CAR T-cell therapy in DLBCL, ALL, FL, and MCL. Key clinical data for CAR T presented at the 2020 ASCO and EHA congress meetings will be included.

For a full overview of the topics covered in the live virtual meeting and follow-up report as well as to confirm your participation in the online sessions:

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.